U.S. Stock News

Why Realty Income is on investors’ radar today Realty Income, an S&P 500 real estate company known for its monthly dividend track record, is drawing fresh attention as investors reassess its income profile and current valuation in light of recent share performance. See our latest analysis for Realty Income. At a share price of US$57.35, Realty Income has seen mixed momentum recently, with a 7 day share price return of 1.74% but a 90 day share price return decline of 2.23%. Its 1 year total...

Earlier this week, Wolfe Research analyst Andy Chen downgraded Madrigal Pharmaceuticals from buy to hold, arguing the company’s valuation looks rich relative to its current performance and questioning market expectations for US$6 billion in annual revenue. The shift highlights a growing debate over how much future value is already embedded in Madrigal’s price, despite strong initial uptake of Rezdiffra and a large potential MASH patient pool. We’ll now examine how this valuation-driven...

Dow Inc. announced that long-time Chief Technology Officer A.N. Sreeram will retire in June 2026, with Andre Argenton assuming the newly combined role of Chief Technology and Sustainability Officer from January 1, 2026, while director Rebecca B. Liebert resigned after becoming Chair of Occidental Chemical Corporation’s board. This reshuffle elevates sustainability and safety oversight into Dow’s top technology role, signaling a tighter link between innovation, environmental performance, and...

If you are wondering whether CSX at around US$35.05 is still a solid entry point or if the easy gains are gone, you are in the right place to size up what the current price might be offering you. The stock has seen mixed returns, with a 1 year return of 10.6% but a 7 day decline of 3.3%, a 30 day decline of 3.6% and a year to date decline of 3.4%, which can change how the market views its potential and its risks. Recent headlines around CSX have focused on operational updates and broader...

At CES 2026, Skyworks Solutions introduced the SKY66424-11, a highly integrated Wi-SUN/LoRaWAN RF front-end module for smart home and smart city use, while also showcasing new automotive-grade connectivity and e-mobility solutions. This product set highlights how Skyworks is tightening its focus on connected infrastructure and vehicles, combining RF integration, filtering and compact design to simplify next-generation deployments. Next, we’ll examine how the new SKY66424-11 smart...

Atlassian (TEAM) is back in focus after its Atlassian Williams F1 Team partnered with dashmoto on a limited edition electric scooter, a branding move that arrives alongside a recently reaffirmed positive analyst rating. See our latest analysis for Atlassian. Atlassian's recent branding push with the Williams F1 tie up and reaffirmed positive analyst view comes against a backdrop of mixed performance, with a 90 day share price return of 8.89% and a 1 year total shareholder return decline of...

What sparked fresh interest in IDEAYA Biosciences? IDEAYA Biosciences (IDYA) has come into focus after UBS highlighted its clinical pipeline. The firm pointed in particular to darovasertib and the DLL3 antibody drug conjugate, and also noted GlaxoSmithKline returning the Werner Helicase and Pol Theta programs. See our latest analysis for IDEAYA Biosciences. Those UBS comments and the upcoming J.P. Morgan Healthcare Conference are landing at a time when IDEAYA’s share price has already seen a...

With no single headline event driving attention today, Masimo (MASI) is on investors’ radars as a medical technology maker with mixed return figures, as well as recent revenue and net income trends that invite closer scrutiny. See our latest analysis for Masimo. Masimo’s recent share price moves have been choppy, with a 7-day share price return of 5.4%, a 30-day share price return decline of 2.68%, and a 1-year total shareholder return loss of 18.79%, suggesting that short-term momentum...

If you have been wondering whether Spotify Technology is still fairly priced or starting to look interesting, you are in the right place to size up what the current share price might be giving you. The stock recently closed at US$569.62, with a 1.9% decline over the last 7 days, a 0.5% decline over 30 days, a 0.9% decline year to date, and an 18.7% gain over the last year, alongside a very large return over 3 years and a 64.1% return over 5 years. Recent attention on Spotify has been shaped...

In early January 2026, Valero Energy announced it would idle its Benicia, California refinery while boosting gasoline imports into the San Francisco Bay Area and offering relocation or outplacement support to affected workers under a formal notification process. At the same time, US actions in Venezuela have reopened the prospect of greater access to heavy crude that Valero’s complex Gulf Coast refineries are designed to process, potentially reshaping its feedstock mix and operating...

With no single headline event driving attention today, Costco Wholesale (COST) is back in focus as investors weigh its recent share performance against the company’s scale, profitability, and membership warehouse model. See our latest analysis for Costco Wholesale. The share price has eased back from recent highs, with a 7 day share price return of 2.35% set against a 90 day share price return decline of 6.40%, while the 5 year total shareholder return of 154.20% points to a very different...

American Tower after a tough stretch for the stock American Tower (AMT) has seen its share price under pressure recently, with a 7.5% decline over the past month and an 8.6% drop over the past 3 months. This performance has prompted investors to reassess the REIT’s current setup. See our latest analysis for American Tower. Looking beyond the recent weakness, American Tower’s 1 year total shareholder return of 2.1% decline and 3 year total shareholder return of 17.8% decline suggest fading...

Why Fabrinet Is Drawing Fresh Momentum Interest Recent technical analysis has pushed Fabrinet (FN) into the spotlight, as the stock is flagged for fitting the Minervini Trend Template, with accelerating earnings, sales growth, and rising analyst estimates capturing momentum focused attention. See our latest analysis for Fabrinet. Fabrinet’s share price has been choppy in the short term, with a 1-day share price return of a 1.81% decline and a 30-day share price return of a 4.18% decline, but...

Krystal Biotech (KRYS) is back in focus after the company scheduled a January 8 investor call to share interim data from the highest dose cohort of its Phase 1 CORAL-1 cystic fibrosis study of KB407. See our latest analysis for Krystal Biotech. Krystal Biotech’s recent product news and conference appearances come against a backdrop of a US$246.37 share price, a 30.52% 3 month share price return and a 57.25% 1 year total shareholder return. This suggests momentum has been building as investors...

Alcoa (AA) has grabbed investor attention after a sharp rally to three year highs, powered by stronger aluminum prices, tight supply conditions, and heavier trading interest in both shares and options. See our latest analysis for Alcoa. That surge in interest is showing up clearly in the numbers, with a 30 day share price return of 41.12% and a 90 day share price return of 69.57%. The 1 year total shareholder return of 76.51% points to strong upward momentum rather than a short lived...

In recent days, AngloGold Ashanti plc has re-emerged in investor discussions as a leveraged gold mining exposure used as a hedge against inflation and market volatility, drawing attention across financial social media. What stands out is that many investors now view AngloGold Ashanti as a more aggressive alternative to larger gold majors, aiming to amplify gold price moves rather than simply track them. We’ll now examine how AngloGold Ashanti’s appeal as a leveraged gold hedge may...

Nutex Health Inc. recently announced that its CEO, CFO, and President presented the company’s physician-led integrated healthcare model at the 2026 J.P. Morgan Healthcare Conference in San Francisco on January 14, 2026. This high-profile appearance offers Nutex Health a platform to explain how its micro-hospital and population health divisions fit into broader healthcare trends. We’ll now examine how Nutex Health’s high-profile J.P. Morgan Healthcare Conference presentation may influence its...

Worthington Enterprises (WOR) has been on many investors’ radar after recent share price moves, with the stock closing at $51.17 as of the latest session and short term returns turning negative. See our latest analysis for Worthington Enterprises. That weaker 1 day share price return of 2.63% and 30 day share price return of 7.27% come after a year to date share price return of 1.52%, while the 1 year total shareholder return of 31.05% and 3 year total shareholder return of 59.40% suggest...

In recent years, UMB Financial has delivered strong fundamental performance, including consistent net interest income growth, an expanded net interest margin, and earnings per share rising faster than revenue. This has been underpinned by a broadened mix of fee-based services such as asset servicing and treasury management, which helps balance pressures facing regional banks. Building on this, we’ll examine how UMB Financial’s resilient fee income and margin gains influence its existing...

Carvana (CVNA) is back in the spotlight after its S&P 500 inclusion and a sharp pickup in retail-unit growth, and investors are now treating the upcoming earnings report as a key check on its profitability push. See our latest analysis for Carvana. The latest move has taken Carvana’s share price to US$450.78, with a 90 day share price return of 25.21% and a 1 year total shareholder return of 128.82%, suggesting momentum has been building alongside S&P 500 inclusion, insider trading plan...

Agnico Eagle Mines (NYSE:AEM) is back in focus after analysts projected year-over-year earnings growth of 59.52% and revenue growth of 35.01% for its upcoming report, alongside a Zacks Rank of #1 (Strong Buy). See our latest analysis for Agnico Eagle Mines. The recent move to a share price of $182.07, alongside a 10.53% 1 month share price return and 12.58% 3 month share price return, sits against a very large 1 year total shareholder return of 121.20%, indicating that momentum has been...

SLB (NYSE:SLB) is back in focus after the U.S. military intervention in Venezuela sparked expectations that American oil companies could help rebuild the country’s damaged energy sector, which is shifting attention to oilfield service specialists. See our latest analysis for SLB. That Venezuela driven spike came on top of an already strong run, with a 90 day share price return of 27.89% and a 1 year total shareholder return of 12.63%, while the 3 year total shareholder return of an 18.90%...

If you are wondering whether MaxLinear's current share price reflects its underlying value, this article will walk through the key numbers so you can judge that for yourself. The stock last closed at US$18.65, with returns of 7.0% over the past week, a 4.4% decline over the past month, 0.8% year to date, and longer term returns of a 9.2% decline over 1 year, a 48.8% decline over 3 years, and a 49.5% decline over 5 years. These mixed returns have kept MaxLinear on the radar of investors who...

Why Gold Royalty Is Suddenly On Investors’ Radar Recent coverage of Gold Royalty (NYSEAM:GROY) has focused on its asset-light model, in which it collects royalties and streams from gold miners instead of operating mines itself. This structure is drawing renewed attention from volatility-tolerant investors. See our latest analysis for Gold Royalty. That speculative interest has coincided with strong recent share price momentum, with a 30-day share price return of 14.77% and a 90-day share...